Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
PUT
Cirrus Logic
CRUS
$6.07B
| $5.28M | ﹤0.01% |
101,800
+45,000
| +79% | +$2.43M |
|
|
QEP
2277
DELISTED
QEP RESOURCES, INC.
QEP
| $5.28M | ﹤0.01% |
551,554
-144,678
| -21% | -$1.31M |
|
|
SGMO
2278
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.28M | ﹤0.01% |
321,648
-42,747
| -12% | -$636K |
|
2279
AMERISAFE
AMSF
$513M
| $5.27M | ﹤0.01% |
85,594
-7,480
| -8% | -$470K |
|
2280
Assured Guaranty
AGO
$3.38B
| $5.27M | ﹤0.01% |
155,597
+94,448
| +154% | +$3.42M |
|
2281
PUT
Mattel
MAT
$4.29B
| $5.25M | ﹤0.01% |
341,600
-25,100
| -7% | -$398K |
|
2282
PUT
Sociedad Química y Minera de Chile
SQM
$21.2B
| $5.25M | ﹤0.01% |
88,400
+4,000
| +5% | +$229K |
|
2283
Tapestry
TPR
$26.1B
| $5.25M | ﹤0.01% |
118,620
-250,182
| -68% | -$10.3M |
|
2284
Philip Morris
PM
$297B
| $5.24M | ﹤0.01% |
49,628
-483,452
| -91% | -$51.5M |
|
2285
PUT
SolarEdge
SEDG
$1.99B
| $5.24M | ﹤0.01% |
139,600
+68,100
| +95% | +$2.34M |
|
2286
ING
ING
$102B
| $5.24M | ﹤0.01% |
283,646
-241,156
| -46% | -$4.42M |
|
2287
PUT
H&R Block
HRB
$6.83B
| $5.23M | ﹤0.01% |
199,600
+22,700
| +13% | +$589K |
|
|
COR
2288
DELISTED
Coresite Realty Corporation
COR
| $5.23M | ﹤0.01% |
45,936
-10,633
| -19% | -$1.21M |
|
2289
Agios Pharmaceuticals
AGIO
$2B
| $5.23M | ﹤0.01% |
+91,470
| New | +$5.76M |
|
2290
Essent Group
ESNT
$6.25B
| $5.23M | ﹤0.01% |
120,404
+113,471
| +1,637% | +$4.94M |
|
2291
Vermilion Energy
VET
$1.73B
| $5.23M | ﹤0.01% |
143,450
+127,346
| +791% | +$4.44M |
|
2292
Adtran
ADTN
$684M
| $5.22M | ﹤0.01% |
269,729
+60,779
| +29% | +$1.35M |
|
2293
CALL
Pultegroup
PHM
$24.8B
| $5.21M | ﹤0.01% |
156,800
-76,500
| -33% | -$2.38M |
|
2294
CALL
Dover
DOV
$27.9B
| $5.21M | ﹤0.01% |
63,881
+26,865
| +73% | +$2.08M |
|
|
ICPT
2295
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.21M | ﹤0.01% |
89,100
-3,200
| -3% | -$202K |
|
2296
CALL
Estee Lauder
EL
$31.2B
| $5.2M | ﹤0.01% |
40,900
-53,400
| -57% | -$6.42M |
|
|
CLVS
2297
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.2M | ﹤0.01% |
76,400
+3,200
| +4% | +$224K |
|
|
ABMD
2298
PUT
DELISTED
Abiomed Inc
ABMD
| $5.19M | ﹤0.01% |
27,700
+18,500
| +201% | +$3.45M |
|
2299
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $5.19M | ﹤0.01% |
44,700
-3,600
| -7% | -$416K |
|
2300
CALL
Hershey
HSY
$37B
| $5.19M | ﹤0.01% |
45,700
+23,400
| +105% | +$2.57M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.